Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

開発途上国における注射避妊薬

S Nair

    Lancet (London, England)
    |June 21, 1986
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Corrigendum to "Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial": [Ann Oncol 36 (2025) 775-785].

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Utility of biopsy and frozen section in detecting malignancy within clinically suspicious verrucous growths: a retrospective study.

    International journal of oral and maxillofacial surgery·2026
    Same author

    Evaluating the impact of image enhancement on radiomics feature stability in MRI of nasopharyngeal carcinoma.

    Radiography (London, England : 1995)·2025
    Same author

    Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Patient Selection and Outcomes in Reirradiation for Head and Neck Cancers: A Prospective Cohort Study.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2025
    Same author

    Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial.

    ESMO open·2024
    Same journal

    Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

    Lancet (London, England)·2026
    Same journal

    Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

    Lancet (London, England)·2026
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    The US Ebola response and the future of global health leadership.

    Lancet (London, England)·2026
    Same journal

    Daniel Mason: a tale of change.

    Lancet (London, England)·2026
    Same journal

    The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

    Lancet (London, England)·2026
    関連記事をすべて見る